Clinical trial
Dendritic Cell-based Immunotherapy in Mesothelioma
NCT00280982 · Erasmus Medical Center, Other · Completed
Key facts
| NCT number | NCT00280982 |
|---|---|
| Title | Dendritic Cell-based Immunotherapy in Mesothelioma |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma |
| Lead sponsor | Erasmus Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignant Pleural Mesothelioma |
| Intervention type | Biological |
| Interventions | tumor lysate-loaded autologous dendritic cells |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jan 24, 2006 |
| Last update posted | Nov 16, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: